Aspire Biopharma Holdings, Inc. financial data

Symbol
ASBP, ASBPW on Nasdaq
Location
194 Candelaro Drive, #233, Humacao, PR
State of incorporation
Cayman Islands
Fiscal year end
December 31
Former names
PowerUp Acquisition Corp. (to 2/19/2025)
Latest financial report
10-K - Q4 2024 - Apr 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.66 % -98.7%
Debt-to-equity -102 % +13.2%
Return On Equity 164 %
Return On Assets -124 % -2624%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.9M shares
Entity Public Float 87M USD +363%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 3.09M USD +130%
Nonoperating Income (Expense) -9.45M USD -263%
Net Income (Loss) Attributable to Parent -12.5M USD -381%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 45.8K USD -43.6%
Assets 6.71M USD -66.4%
Liabilities, Current 15.6M USD +3772%
Liabilities 15.6M USD +3772%
Retained Earnings (Accumulated Deficit) -24.4M USD -116%
Stockholders' Equity Attributable to Parent -15.6M USD -4734%
Liabilities and Equity 6.71M USD -66.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.26M USD -1141%
Net Cash Provided by (Used in) Financing Activities 2.26M USD
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -182K USD -129%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 125K USD -78.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 8.8M USD -19.7%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%